Copyright
©2005 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2005; 11(2): 187-192
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.187
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.187
Variables | No. of patients (%) |
Age (mean, yr) (±SD) | 50.4±12.6 |
Male | 44(73) |
Cirrhosis | 47(78) |
Child- Pugh's class A | 43(72) |
Serum AFP < 20 ng/mL | 19(32) |
20-103 ng/mL | 29(48) |
>103 ng/mL | 12(20) |
HBsAg (+) | 47(78) |
Anti-HCV (+) | 32(53) |
Size of HCC <3 cm | 17(28) |
3-10 cm | 22(37) |
>10 cm | 2(35) |
Edmondson-Steiner's grade I | 13(22) |
Grade II | 11(18) |
Grade III | 18(30) |
Grade IV | 18(30) |
Absent or incomplete capsule | 39(65) |
Vascular permeation | 33(55) |
Daughter nodules | 31(52) |
- Citation: Sheen IS, Jeng KS, Shih SC, Kao CR, Chang WH, Wang HY, Wang PC, Wang TE, Shyung LR, Chen CZ. Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(2): 187-192
- URL: https://www.wjgnet.com/1007-9327/full/v11/i2/187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i2.187